JPH0423751B2 - - Google Patents
Info
- Publication number
- JPH0423751B2 JPH0423751B2 JP59177347A JP17734784A JPH0423751B2 JP H0423751 B2 JPH0423751 B2 JP H0423751B2 JP 59177347 A JP59177347 A JP 59177347A JP 17734784 A JP17734784 A JP 17734784A JP H0423751 B2 JPH0423751 B2 JP H0423751B2
- Authority
- JP
- Japan
- Prior art keywords
- gel
- cellulose
- buffer
- column
- lpf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920002678 cellulose Polymers 0.000 claims description 36
- 239000001913 cellulose Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 28
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 19
- 238000001042 affinity chromatography Methods 0.000 claims description 16
- 239000002245 particle Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 5
- -1 sulfuric acid ester Chemical class 0.000 claims description 5
- 239000012374 esterification agent Substances 0.000 claims description 4
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims description 3
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 claims description 3
- 230000003472 neutralizing effect Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 46
- 239000000499 gel Substances 0.000 description 40
- 235000010980 cellulose Nutrition 0.000 description 31
- 239000011780 sodium chloride Substances 0.000 description 23
- 102000004169 proteins and genes Human genes 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 239000000872 buffer Substances 0.000 description 19
- 239000008363 phosphate buffer Substances 0.000 description 17
- 238000000746 purification Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 14
- 241000700605 Viruses Species 0.000 description 14
- 239000002994 raw material Substances 0.000 description 14
- 238000010828 elution Methods 0.000 description 13
- 239000007853 buffer solution Substances 0.000 description 11
- XZEUAXYWNKYKPL-URLMMPGGSA-N ormeloxifene Chemical compound C1([C@@H]2[C@H](C3=CC=C(C=C3OC2(C)C)OC)C=2C=CC(OCCN3CCCC3)=CC=2)=CC=CC=C1 XZEUAXYWNKYKPL-URLMMPGGSA-N 0.000 description 11
- 238000001179 sorption measurement Methods 0.000 description 11
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 10
- 229920000669 heparin Polymers 0.000 description 10
- 229960002897 heparin Drugs 0.000 description 10
- 241000588832 Bordetella pertussis Species 0.000 description 9
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 7
- 235000011613 Pinus brutia Nutrition 0.000 description 7
- 241000018646 Pinus brutia Species 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920001499 Heparinoid Polymers 0.000 description 5
- 241000710842 Japanese encephalitis virus Species 0.000 description 5
- 241000711798 Rabies lyssavirus Species 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000002554 heparinoid Substances 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 4
- 102000043296 Lipoprotein lipases Human genes 0.000 description 4
- 239000004019 antithrombin Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011067 equilibration Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000011403 purification operation Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 241000712461 unidentified influenza virus Species 0.000 description 4
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 3
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 239000012149 elution buffer Substances 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000002429 anti-coagulating effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000701931 Canine parvovirus Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101710154643 Filamentous hemagglutinin Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000285721 Ibaraki virus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 102000004211 Platelet factor 4 Human genes 0.000 description 1
- 108090000778 Platelet factor 4 Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000702619 Porcine parvovirus Species 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229940019700 blood coagulation factors Drugs 0.000 description 1
- OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 125000001547 cellobiose group Chemical group 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- VFNGKCDDZUSWLR-UHFFFAOYSA-N disulfuric acid Chemical compound OS(=O)(=O)OS(O)(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004023 fresh frozen plasma Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 229940025770 heparinoids Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- HIFJUMGIHIZEPX-UHFFFAOYSA-N sulfuric acid;sulfur trioxide Chemical compound O=S(=O)=O.OS(O)(=O)=O HIFJUMGIHIZEPX-UHFFFAOYSA-N 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/291—Gel sorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59177347A JPS6154450A (ja) | 1984-08-24 | 1984-08-24 | 群特異性を有するアフイニテイクロマトグラフイ用ゲルおよびその製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59177347A JPS6154450A (ja) | 1984-08-24 | 1984-08-24 | 群特異性を有するアフイニテイクロマトグラフイ用ゲルおよびその製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6154450A JPS6154450A (ja) | 1986-03-18 |
| JPH0423751B2 true JPH0423751B2 (ru) | 1992-04-23 |
Family
ID=16029377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59177347A Granted JPS6154450A (ja) | 1984-08-24 | 1984-08-24 | 群特異性を有するアフイニテイクロマトグラフイ用ゲルおよびその製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6154450A (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007092034A (ja) * | 2005-09-01 | 2007-04-12 | Chisso Corp | 球状硫酸化セルロース及びその製造方法 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63209750A (ja) * | 1987-02-25 | 1988-08-31 | Kanegafuchi Chem Ind Co Ltd | 血液凝固第８因子精製用吸着体およびそれを用いた血液凝固第８因子の精製法 |
| JP2627186B2 (ja) * | 1989-01-23 | 1997-07-02 | 財団法人化学及血清療法研究所 | レトロウイルスの精製方法 |
| WO1991013976A1 (en) * | 1990-03-14 | 1991-09-19 | Yamanouchi Pharmaceutical Co., Ltd. | Process for producing purified tissue plasminogen activator or its derivative |
| AU4472801A (en) * | 2000-04-07 | 2001-10-23 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Inactivated japanese B encephalitis vaccine and process for producing the same |
| GB2429708B (en) * | 2005-09-01 | 2010-06-02 | Chisso Corp | Spherical sulfated cellulose |
| GB2465301B (en) * | 2005-09-01 | 2010-06-30 | Chisso Corp | Spherical sulfated cellulose |
| JP2008222604A (ja) * | 2007-03-09 | 2008-09-25 | Chisso Corp | 化粧料配合剤及びそれを含む化粧料組成物 |
| JP7239104B2 (ja) * | 2019-02-05 | 2023-03-14 | 国立大学法人福井大学 | タンパク質吸着剤及びその製造方法 |
-
1984
- 1984-08-24 JP JP59177347A patent/JPS6154450A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007092034A (ja) * | 2005-09-01 | 2007-04-12 | Chisso Corp | 球状硫酸化セルロース及びその製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6154450A (ja) | 1986-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR920009733B1 (ko) | 인플루엔자 바이러스의 정제방법 | |
| EP0208215B1 (en) | Purification of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices | |
| KR920009731B1 (ko) | 일본뇌염 바이러스의 정제방법 | |
| KR880002586B1 (ko) | B형 간염 바이러스 표면 항원의 정제방법 | |
| CA1251398A (en) | Method for purification of rabic virus | |
| KR890001927B1 (ko) | 섬유질 헤마글루티닌의 정제방법 | |
| US5639857A (en) | Ultrapurification of factor IX and other vitamin k-dependent proteins | |
| JPS58201794A (ja) | ヒトインターフェロンβの濃縮精製法 | |
| JPH0423751B2 (ru) | ||
| JPH0427504B2 (ru) | ||
| CA1114293A (en) | Purification of pertussis haemagglutinins | |
| KR920009730B1 (ko) | 백일해 성분 백신 및 백일해 항원, 디프테리아 톡소이드 및 파상풍 톡소이드의 혼합백신의 제조방법 | |
| JPH0423752B2 (ru) | ||
| JP2511500B2 (ja) | 胎盤組織タンパク質ｐｐ▲下４▼の精製法 | |
| AU641119B2 (en) | Ultrapurification of factor IX and other vitamin K-dependent proteins | |
| JPS59231097A (ja) | 均質ヒト免疫インターフェロンサブタイプ２１ｋおよびその製造法 | |
| EP0170162B1 (en) | Method for the purification of leukocytosis-promoting factor haemagglutinin | |
| JPS632936B2 (ru) | ||
| JP2739232B2 (ja) | 生物学的親和性を有するセルロースゲルの使用方法 | |
| JPS641446B2 (ru) | ||
| JPS641447B2 (ru) | ||
| JPS6130528A (ja) | Ｌｐｆ−ｈａの精製方法 | |
| JPH0768274B2 (ja) | プラスミノゲンの製造方法 | |
| JPS59164727A (ja) | Ｂ型肝炎ウイルス表面抗原の精製方法 | |
| JPS641445B2 (ru) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |